# Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm

> **NCT01603459** · PHASE3 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 155 (actual)

## Conditions studied

- Spasticity of the Upper and Lower Limb Due to Cerebral Causes

## Interventions

- **DRUG:** IncobotulinumtoxinA

## Key facts

- **NCT ID:** NCT01603459
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603459, "Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01603459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*